Reaction

Breast Enlargement reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,241 reports · 55 co-occurring drugs

As of the last recalculation, Breast Enlargement appears in 3,241 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is RISPERIDONE (PRR 25.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Risperidone	463	25.9	26.0
Paliperidone Palmitate	102	21.0	21.0
Paliperidone	69	19.4	19.4
Bicalutamide	29	12.3	12.3
Finasteride	110	12.1	12.1
Drospirenone And Ethinyl Estradiol	77	11.4	11.5
Olanzapine Pamoate	60	9.6	9.6
Ziprasidone	24	8.8	8.8
Leuprolide Acetate	102	8.7	8.7
Estradiol	108	8.3	8.3
Ziprasidone Mesylate	18	8.1	8.2
Progesterone	28	7.9	7.9
Etonogestrel And Ethinyl Estradiol	27	7.9	7.9
Levonorgestrel	210	7.1	7.1
Goserelin	14	6.7	6.7
Dutasteride	8	6.3	6.3
Olanzapine	100	6.1	6.1
Apalutamide	11	6.0	6.0
Conjugated Estrogens And Medroxyprogesterone Acetate	22	6.0	6.0
Raloxifene Hydrochloride	13	5.7	5.7
Fexofenadine Hcl	8	5.6	5.6
Estradiol Gel 0.1%	38	5.5	5.5
Estradiol Transdermal	38	5.4	5.5
Anastrozole Tablets	17	5.1	5.1
Estrogens, Conjugated	43	4.7	4.7
Conjugated Estrogens	42	4.7	4.7
Atomoxetine Hydrochloride	17	4.6	4.6
Lithium	18	4.6	4.6
Lithium Bromatum	18	4.6	4.6
Haloperidol	17	4.5	4.5
Haloperidol Lactate	17	4.4	4.4
Lurasidone Hydrochloride	14	4.3	4.3
Sotalol Hydrochloride	11	4.3	4.3
Anastrozole	24	4.2	4.2
Aripiprazole Oral	27	4.2	4.2
Aripiprazole Orally Disintegrating	27	4.2	4.2
Enzalutamide	38	4.2	4.2
Etonogestrel	29	3.9	3.9
Orlistat	15	3.7	3.7
Aripiprazole	68	3.6	3.6
Ribociclib	17	3.5	3.5
Carboxymethylcellulose Sodium	5	3.4	3.4
Medroxyprogesterone Acetate	26	3.4	3.4
Asenapine Maleate	4	3.0	3.0
Dolutegravir Sodium	4	2.9	2.9
Brexpiprazole	7	2.7	2.7
Ivacaftor	3	2.4	2.4
Teriparatide	39	2.2	2.2
Elexacaftor, Tezacaftor, And Ivacaftor	4	2.1	2.1
Mometasone Furoate And Formoterol Fumarate Dihydrate	5	2.1	2.1
Dornase Alfa	5	1.6	1.6
Relugolix	6	1.6	1.6
Somatropin	16	1.4	1.4
Ledipasvir And Sofosbuvir	4	1.3	1.3
Copper	4	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.